| Dual mTORC1/2 inhibitor AZD2014 diminishes myeloid-derived suppressor cells accumulation in ovarian cancer and delays tumor growth R Pi, Y Yang, X Hu, H Li, H Shi, Y Liu, X Wang, A Tong, T Lu, Y Wei, ... Cancer Letters 523, 72-81, 2021 | 14 | 2021 |
| Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles? T Lan, X Wei Molecular Biomedicine 2 (1), 1-3, 2021 | 2 | 2021 |
| The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin A X Liu, T Yu, Y Hu, L Zhang, J Zheng, X Wei Molecular Biomedicine 2 (1), 1-12, 2021 | 13 | 2021 |
| Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19 Y Ni, A Alu, H Lei, Y Wang, M Wu, X Wei Molecular Biomedicine 2 (1), 1-26, 2021 | 27 | 2021 |
| Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin Y Cheng, F Mo, Q Li, X Han, H Shi, S Chen, Y Wei, X Wei Molecular cancer 20 (1), 1-21, 2021 | 104 | 2021 |
| Mesenchymal stem/stromal cells in cancer therapy T Lan, M Luo, X Wei Journal of Hematology & Oncology 14 (1), 1-16, 2021 | 155 | 2021 |
| mRNA vaccine: a potential therapeutic strategy Y Wang, Z Zhang, J Luo, X Han, Y Wei, X Wei Molecular Cancer 20 (1), 1-23, 2021 | 277 | 2021 |
| Role of lysosomes in physiological activities, diseases, and therapy Z Zhang, P Yue, T Lu, Y Wang, Y Wei, X Wei Journal of Hematology & Oncology 14 (1), 1-39, 2021 | 145 | 2021 |
| Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting M Xu, Y Wang, R Xia, Y Wei, X Wei Cell Proliferation 54 (10), e13115, 2021 | 180 | 2021 |
| Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy S Chen, F Qin, M Wang, Y Wei, Z Qian, X Wei Nano Research, 1-19, 2021 | 6 | 2021 |
| Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response D Wan, H Que, L Chen, T Lan, W Hong, C He, J Yang, Y Wei, X Wei Nano Letters 21 (19), 7960-7969, 2021 | 28 | 2021 |
| S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis F Ye, X Lin, Z Chen, F Yang, S Lin, J Yang, H Chen, H Sun, L Wang, ... Signal transduction and targeted therapy 6 (1), 1-12, 2021 | 29 | 2021 |
| Noncoding RNAs in tumor metastasis: molecular and clinical perspectives QL Liu, Z Zhang, X Wei, ZG Zhou Cellular and Molecular Life Sciences, 1-28, 2021 | 24 | 2021 |
| Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine C Fang, F Mo, L Liu, J Du, M Luo, K Men, F Na, W Wang, H Yang, X Wei Cellular & molecular immunology 18 (9), 2211-2223, 2021 | 66 | 2021 |
| A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus C He, J Yang, X He, W Hong, H Lei, Z Chen, G Shen, L Yang, J Li, ... MedComm 2 (3), 430-441, 2021 | 41 | 2021 |
| Targeted Inhibition of ROCK Specifically in the Polarization Interstitial Macrophages Suppresses Pulmonary Fibrosis Q Li, Y Cheng, Z Bi, X Ma, Y Wei, X Wei | | 2021 |
| CCL5/CCR5 axis in human diseases and related treatments Z Zeng, T Lan, Y Wei, X Wei Genes & Diseases, 2021 | 150 | 2021 |
| Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials F Tang, Y Tie, YQ Wei, CQ Tu, XW Wei Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 188606, 2021 | 24 | 2021 |
| DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer M Wang, S Chen, Y Wei, X Wei Acta Pharmaceutica Sinica B, 2021 | 24 | 2021 |
| Graphene promotes lung cancer metastasis through Wnt signaling activation induced by DAMPs Z Bi, L Li, J Yang, X Li, F Mo, T Lu, Y Song, Z Cheng, Q Fu, H Lei, X He, ... Nano Today 39, 101175, 2021 | 6 | 2021 |
